Biomind Labs Inc.
BMND
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -448.93% | 11.76% | -74.40% | -138.77% | 599.42% |
| Total Depreciation and Amortization | -- | -- | -100.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,858.86% | -34.17% | 149.59% | 82.25% | -383.33% |
| Change in Net Operating Assets | -0.83% | -56.95% | -1.06% | 2,620.00% | 79.91% |
| Cash from Operations | -26.61% | -296.45% | 3,840.00% | 100.49% | 7.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -67.69% | 16,150.00% | -- | -- | 51.79% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -67.69% | 16,150.00% | -- | -- | 67.06% |
| Foreign Exchange rate Adjustments | -185.29% | 151.26% | -3,880.00% | -106.25% | -78.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.55% | 36,400.00% | -- | 100.00% | 56.71% |